You just read:

Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia

News provided by

Bayer HealthCare Pharmaceuticals Inc.

Apr 16, 2013, 05:00 ET